Affinage · Plasmodium

PF3D7_0927000

HSP90 co-chaperone p23

Audit flag: identity unverified
Annotated
2026-09-08
91 papers in source corpus 5 papers cited in narrative 7 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PF3D7_0927000 (p23) is a co-chaperone of the P. falciparum Hsp90 (PfHsp90) chaperone machinery that also possesses intrinsic, Hsp90-independent chaperone activity, suppressing thermal aggregation of model substrates such as citrate synthase in vitro (PMID:20140477, PMID:29191421). It binds PfHsp90 directly and inhibits its ATPase activity, with binding mediated by residues K91, H93, W94, and K96 identified through model-guided mutagenesis (PMID:20140477). p23 engages the same region of PfHsp90 as the co-chaperone PfAha1 and competes with it for binding in an MgCl2- and ATP-dependent manner, positioning p23 as a regulator of the composition and cycling of the PfHsp90 multichaperone complex (PMID:22100910). The P. falciparum genome encodes two divergent p23 proteins, Pfp23A (PF3D7_0927000) and Pfp23B, sharing only ~13% identity; both behave as elongated monomers in solution, display intrinsic chaperone activity, and inhibit PfHsp90 ATPase activity, with Pfp23A being the more thermally and chemically stable of the two (PMID:29191421). Beyond these in vitro biochemical properties, the cellular and parasite-stage functions of PF3D7_0927000 have not been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2010 Medium

    Establishing whether the parasite p23 homolog is a functional chaperone and Hsp90 partner, this work showed recombinant Pfp23 both suppresses substrate aggregation on its own and binds PfHsp90 while inhibiting its ATPase activity, defining it as a bona fide co-chaperone with intrinsic activity.

    Evidence In vitro aggregation suppression, protein-protein interaction, and ATPase assays with recombinant proteins

    PMID:20140477

    Open questions at the time
    • Single lab, in vitro reconstitution only; no cellular or parasite-based validation
    • No structural determination of the interaction
  2. 2010 Medium

    To localize the interaction interface, model-guided mutagenesis pinpointed Pfp23 residues K91, H93, W94, and K96 as required for PfHsp90 binding, giving a residue-level map of the co-chaperone contact.

    Evidence Homology modeling of the Pfp23-PfHsp90 complex with site-directed mutagenesis

    PMID:20140477

    Open questions at the time
    • Interface inferred from a homology model, not a crystal or cryo-EM structure
    • Contribution of PfHsp90-side residues not defined
  3. 2011 Medium

    Addressing how p23 fits within the wider co-chaperone network, competition pull-downs showed Pfp23 competes with PfAha1 for PfHsp90 in an MgCl2- and ATP-dependent manner, implying p23 helps set the composition of the chaperone cycle.

    Evidence GST pull-down competition assay between Pfp23 and PfAha1 for PfHsp90

    PMID:22100910

    Open questions at the time
    • Single method, single lab
    • Functional consequence of the competition for client maturation not tested
  4. 2017 High

    Resolving the paralog question, biophysical and functional characterization showed P. falciparum encodes two highly divergent p23 proteins, both of which are elongated monomers with intrinsic chaperone and PfHsp90 ATPase-inhibiting activity, with PF3D7_0927000 (Pfp23A) being the more stable.

    Evidence Recombinant protein production, SAXS, thermal/chemical denaturation, aggregation suppression and ATPase inhibition assays

    PMID:29191421

    Open questions at the time
    • Distinct in vivo roles of Pfp23A versus Pfp23B not established
    • No structure of the p23-Hsp90 complex

Open questions

Synthesis pass · forward-looking unresolved questions
  • The cellular localization, parasite developmental role, client repertoire, and in vivo essentiality of PF3D7_0927000 remain unaddressed by the available corpus.
  • No genetic knockout/knockdown phenotype reported
  • No in-parasite localization or expression-timing data specific to PF3D7_0927000
  • No identified Hsp90 client whose maturation depends on p23

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Complex memberships
PfHsp90 multichaperone complex

Evidence

Reading pass · 7 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2010 Recombinant P. falciparum p23 (Pfp23/PF3D7_0927000) exhibits intrinsic chaperone activity, as demonstrated by its ability to suppress citrate synthase aggregation at 45°C in vitro. In vitro aggregation suppression assay using recombinant Pfp23 and citrate synthase as substrate Cellular and molecular life sciences : CMLS Medium 20140477
2010 Recombinant Pfp23 (PF3D7_0927000) interacts directly with PfHsp90 and suppresses its ATPase activity in vitro. In vitro protein-protein interaction assay with recombinant proteins; ATPase activity assay Cellular and molecular life sciences : CMLS Medium 20140477
2010 Site-directed mutagenesis of modeled Pfp23-PfHsp90 complex identified residues K91, H93, W94, and K96 in Pfp23 as crucial for binding to PfHsp90. Homology modeling of Pfp23-PfHsp90 complex combined with site-directed mutagenesis Cellular and molecular life sciences : CMLS Medium 20140477
2011 Pfp23 (PF3D7_0927000) competes with PfAha1 for binding to PfHsp90 under MgCl2- and ATP-dependent conditions, as shown by GST pull-down competition assay. GST pull-down competition assay between Pfp23 and PfAha1 for PfHsp90 binding The international journal of biochemistry & cell biology Medium 22100910
2014 Pfp23 (PF3D7_0927000) is one of five experimentally validated co-chaperones of PfHsp90 in P. falciparum; it has been shown to interact with PfHsp90 and regulate its activity. Review summarizing experimental co-immunoprecipitation and interaction data from primary studies Parasitology Low 24560171
2017 The P. falciparum genome encodes two putative p23 proteins (Pfp23A/PF3D7_0927000 and Pfp23B) with only 13% identity to each other and ~20% identity to human p23. Both recombinant proteins behaved as elongated monomers in solution, showed intrinsic chaperone activity (suppressing thermal aggregation of model substrates), and inhibited PfHsp90 ATPase activity. Pfp23A was more thermally and chemically stable than Pfp23B. Recombinant protein production; small-angle X-ray scattering (SAXS) for solution structure; thermal/chemical denaturation; in vitro aggregation suppression assays; ATPase inhibition assay International journal of biological macromolecules High 29191421
2002 Mass spectrometric analysis identified an acetylation site on PfHsp90 that overlaps with the Aha1 and p23 (PF3D7_0927000) binding domain, suggesting this modification modulates Hsp90 multichaperone complex assembly including p23 binding. Treatment with a histone deacetylase inhibitor resulted in partial dissociation of the PfHsp90 complex. Mass spectrometry of PfHsp90 expressed in P. falciparum; HDAC inhibitor treatment followed by complex analysis The Journal of biological chemistry Low 20837488

Source papers

Stage 0 corpus · 91 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2003 Heat shock protein 90 function is essential for Plasmodium falciparum growth in human erythrocytes. The Journal of biological chemistry 189 12584193
2010 Heat shock protein 90 as a drug target against protozoan infections: biochemical characterization of HSP90 from Plasmodium falciparum and Trypanosoma evansi and evaluation of its inhibitor as a candidate drug. The Journal of biological chemistry 139 20837488
2007 Chaperoning a cellular upheaval in malaria: heat shock proteins in Plasmodium falciparum. Molecular and biochemical parasitology 110 17307260
2012 Charged linker sequence modulates eukaryotic heat shock protein 90 (Hsp90) chaperone activity. Proceedings of the National Academy of Sciences of the United States of America 105 22315411
2016 A broad analysis of resistance development in the malaria parasite. Nature communications 100 27301419
2007 Systems analysis of chaperone networks in the malarial parasite Plasmodium falciparum. PLoS computational biology 94 17941702
2011 Intracellular protozoan parasites of humans: the role of molecular chaperones in development and pathogenesis. Protein and peptide letters 90 20955165
2009 Plasmodial heat shock proteins: targets for chemotherapy. FEMS immunology and medical microbiology 85 20041948
2003 The heat shock protein 90 of Plasmodium falciparum and antimalarial activity of its inhibitor, geldanamycin. Malaria journal 82 14514358
2001 Host chaperones are recruited in membrane-bound complexes by Plasmodium falciparum. The Journal of biological chemistry 80 11711553
2004 Recurrent fever promotes Plasmodium falciparum development in human erythrocytes. The Journal of biological chemistry 70 15339915
2010 A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90. Journal of medicinal chemistry 64 20349996
2011 Characterisation of the Plasmodium falciparum Hsp70-Hsp90 organising protein (PfHop). Cell stress & chaperones 58 22005844
2005 The FK506-binding protein of the malaria parasite, Plasmodium falciparum, is a FK506-sensitive chaperone with FK506-independent calcineurin-inhibitory activity. Molecular and biochemical parasitology 56 15850699
1994 Molecular characterization of the heat shock protein 90 gene of the human malaria parasite Plasmodium falciparum. Molecular and biochemical parasitology 56 7838176
2012 Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin. Antimicrobial agents and chemotherapy 52 22615284
2010 Structure of the ATP-binding domain of Plasmodium falciparum Hsp90. Proteins 52 20635416
2005 Plasmodium falciparum calcineurin and its association with heat shock protein 90: mechanisms for the antimalarial activity of cyclosporin A and synergism with geldanamycin. Molecular and biochemical parasitology 51 15811524
2015 Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development. Antimicrobial agents and chemotherapy 47 26711771
2021 A heat-shock response regulated by the PfAP2-HS transcription factor protects human malaria parasites from febrile temperatures. Nature microbiology 45 34400833
2010 Malaria heat shock proteins: drug targets that chaperone other drug targets. Infectious disorders drug targets 44 20334623
2014 Differences in conformational dynamics between Plasmodium falciparum and human Hsp90 orthologues enable the structure-based discovery of pathogen-selective inhibitors. Journal of medicinal chemistry 42 24580531
2009 The complementation of yeast with human or Plasmodium falciparum Hsp90 confers differential inhibitor sensitivities. Molecular and biochemical parasitology 40 19320098
1994 Sequence, transcript characterization and polymorphisms of a Plasmodium falciparum gene belonging to the heat-shock protein (HSP) 90 family. Gene 38 7828879
2016 Inhibition of Plasmodium falciparum Hsp90 Contributes to the Antimalarial Activities of Aminoalcohol-carbazoles. Journal of medicinal chemistry 35 27312008
2010 Chaperone expression profiles correlate with distinct physiological states of Plasmodium falciparum in malaria patients. Malaria journal 35 20719001
2001 A novel tetratricopeptide repeat (TPR) containing PP5 serine/threonine protein phosphatase in the malaria parasite, Plasmodium falciparum. BMC microbiology 35 11737864
2018 Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity. Antimicrobial agents and chemotherapy 34 29339390
2013 A purine analog synergizes with chloroquine (CQ) by targeting Plasmodium falciparum Hsp90 (PfHsp90). PloS one 34 24098696
2016 In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin. Malaria journal 33 27903279
2007 Three-dimensional structure of heat shock protein 90 from Plasmodium falciparum: molecular modelling approach to rational drug design against malaria. Journal of biosciences 32 17536172
2013 Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance. Pathogens (Basel, Switzerland) 30 25436880
2019 Harmicines - harmine and cinnamic acid hybrids as novel antiplasmodial hits. European journal of medicinal chemistry 28 31812035
2022 Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents. European journal of medicinal chemistry 26 35551033
2021 General Structural and Functional Features of Molecular Chaperones. Advances in experimental medicine and biology 26 34569020
2017 Identification and characterization of the antiplasmodial activity of Hsp90 inhibitors. Malaria journal 26 28724415
1994 Immunogenicity and antigenicity of a Plasmodium falciparum protein fraction (90-110 kDa) able to protect squirrel monkeys against asexual blood stages. Vaccine 26 8303938
2012 Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii. Malaria journal 24 22361388
2013 Heat shock protein 90 inhibitors as broad spectrum anti-infectives. Current pharmaceutical design 23 22920905
2009 Crystallographic structure of the tetratricopeptide repeat domain of Plasmodium falciparum FKBP35 and its molecular interaction with Hsp90 C-terminal pentapeptide. Protein science : a publication of the Protein Society 23 19691130
2019 A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90. Scientific reports 21 31611575
2013 A review of recent patents on the protozoan parasite HSP90 as a drug target. Recent patents on biotechnology 21 23002958
2001 Antibodies specific for heat shock proteins in human and murine malaria. Microbes and infection 21 11369272
2021 Inhibitors of the Plasmodium falciparum Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future. Cells 18 34831072
2010 Characterization of Plasmodium falciparum co-chaperone p23: its intrinsic chaperone activity and interaction with Hsp90. Cellular and molecular life sciences : CMLS 17 20140477
2022 Hsp90 and Associated Co-Chaperones of the Malaria Parasite. Biomolecules 16 35892329
2019 Structural studies of the Hsp70/Hsp90 organizing protein of Plasmodium falciparum and its modulation of Hsp70 and Hsp90 ATPase activities. Biochimica et biophysica acta. Proteins and proteomics 16 31525467
2019 Plasmodium falciparum R2TP complex: driver of parasite Hsp90 function. Biophysical reviews 16 31734827
2014 Co-chaperones of Hsp90 in Plasmodium falciparum and their concerted roles in cellular regulation. Parasitology 16 24560171
2024 Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome. Cell chemical biology 15 38492573
2023 Pharmacophore Model-Based Virtual Screening Workflow for Discovery of Inhibitors Targeting Hsp90. ACS omega 15 37867657
2021 Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action. European journal of medicinal chemistry 15 34274829
2021 Plasmodium berghei Hsp90 contains a natural immunogenic I-Ab-restricted antigen common to rodent and human Plasmodium species. Current research in immunology 15 35492393
2018 Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 15 30542925
2018 In silico identification and evaluation of potential interaction of Azadirachta indica phytochemicals with Plasmodium falciparum heat shock protein 90. Journal of molecular graphics & modelling 15 30544005
2020 Biophysical analysis of Plasmodium falciparum Hsp70-Hsp90 organising protein (PfHop) reveals a monomer that is characterised by folded segments connected by flexible linkers. PloS one 14 32343703
2020 Novel Harmicines with Improved Potency against Plasmodium. Molecules (Basel, Switzerland) 14 32977642
2022 Inhibition of Plasmodium falciparum Hsp70-Hop partnership by 2-phenylthynesulfonamide. Frontiers in molecular biosciences 13 36177352
2019 Thermodynamic analysis of interactions of the Hsp90 with adenosine nucleotides: A comparative perspective. International journal of biological macromolecules 13 30797004
2020 Solution structure of Plasmodium falciparum Hsp90 indicates a high flexible dimer. Archives of biochemistry and biophysics 12 32679196
2014 Exploring in vitro and in vivo Hsp90 inhibitors activity against human protozoan parasites. Bioorganic & medicinal chemistry letters 12 25547934
2024 Discovery of harmiprims, harmine-primaquine hybrids, as potent and selective anticancer and antimalarial compounds. Bioorganic & medicinal chemistry 11 38677112
2023 The Plasmodium falciparum exported J domain proteins fine-tune human and malarial Hsp70s: pathological exploitation of proteostasis machinery. Frontiers in molecular biosciences 11 37457831
2021 Identification of Plasmodium falciparum heat shock 90 inhibitors via molecular docking. Bioorganic & medicinal chemistry letters 11 33513390
2017 Comparative studies of the low-resolution structure of two p23 co-chaperones for Hsp90 identified in Plasmodium falciparum genome. International journal of biological macromolecules 11 29191421
2014 Plasmodium falciparum Hop: detailed analysis on complex formation with Hsp70 and Hsp90. Biochemical and biophysical research communications 11 25482441
2013 Targeting heat shock protein 90 for malaria. Mini reviews in medicinal chemistry 11 24070209
2011 Molecular analysis of Plasmodium falciparum co-chaperone Aha1 supports its interaction with and regulation of Hsp90 in the malaria parasite. The international journal of biochemistry & cell biology 11 22100910
2023 Plasmodium-Resistant Indole Diterpenoid Biosynthesis Gene Cluster Derived from Aspergillus oryzae Was Activated by Exogenous P450 Gene Ast B. Journal of natural products 10 37257055
2021 Febrile temperature causes transcriptional downregulation of Plasmodium falciparum Sirtuins through Hsp90-dependent epigenetic modification. Molecular microbiology 10 33538363
2021 Molecular docking and molecular dynamics simulation identify a novel Radicicol derivative that predicts exclusive binding to Plasmodium falciparum Topoisomerase VIB. Journal of biomolecular structure & dynamics 10 33650468
2021 Violacein-Induced Chaperone System Collapse Underlies Multistage Antiplasmodial Activity. ACS infectious diseases 9 33689276
2018 Model System Identifies Kinetic Driver of Hsp90 Inhibitor Activity against African Trypanosomes and Plasmodium falciparum. Antimicrobial agents and chemotherapy 9 29866861
2025 Two sides of the same coin: heat shock proteins as biomarkers and therapeutic targets for some complex diseases. Frontiers in molecular biosciences 8 40051500
2024 In silico screening of selective ATP mimicking inhibitors targeting the Plasmodium falciparum Grp94. Journal of biomolecular structure & dynamics 7 38498364
2024 Plasmodium falciparum heat shock proteins as antimalarial drug targets: An update. Cell stress & chaperones 7 38518861
2024 Characterization and Inhibition of the Chaperone Function of Plasmodium falciparum Glucose-Regulated Protein 94 kDa (Pf Grp94). Proteins 7 39670568
2021 Role of Hsp90 in Plasmodium falciparum Malaria. Advances in experimental medicine and biology 6 34569023
2024 Ursolic acid acetate and iso-mukaadial acetate bind to Plasmodium falciparum Hsp90, abrogating its chaperone function in vitro. Naunyn-Schmiedeberg's archives of pharmacology 5 38252299
2023 Plasmodium female gamete surface HSP90 is a key determinant for fertilization. mBio 5 38131664
2022 Heat Shock Protein 90 Regulates the Activity of Histone Deacetylase Sir2 in Plasmodium falciparum. mSphere 5 36121150
2024 Auto QSAR-based active learning docking for hit identification of potential inhibitors of Plasmodium falciparum Hsp90 as antimalarial agents. PloS one 4 39585817
2025 Hsp90 and associates shaping parasite biology. mSphere 3 40990539
2025 Plasmodium knowlesi Heat Shock Protein 90s: In Silico Analysis Reveals Unique Druggable Structural Features. International journal of molecular sciences 1 41465491
2025 The possibilities and challenges associated with selective targeting Plasmodium falciparum Hsp90 for Malaria. Transactions of the Royal Society of South Africa. Royal Society of South Africa 1 41836916
2024 Study of the naturally occurring lignan brachangobinan A as antiplasmodial agent: Synthesis, biological evaluation, and in silico prediction. Chemico-biological interactions 1 39710055
2022 Analysis of Plasmodium falciparum myosin B ATPase activity and structure in complex with the calmodulin-like domain of its light chain MLC-B. The Journal of biological chemistry 1 36273584
2026 Synthetic quinolone-tethered aminoguanidine derivatives exhibit potent anti-plasmodial activity. International journal of antimicrobial agents 0 41921671
2026 Heat shock protein Gp96 (Grp94) in malaria: functional insights at the host-parasite interface and therapeutic perspectives. Frontiers in cell and developmental biology 0 41970953
2025 Investigation of a cryptic ligand binding site on Plasmodium falciparum Hsp90. Bioorganic & medicinal chemistry 0 40907219
2025 Shared Binding Site but Divergent Resistance Profiles Uncover Novel Resistance Mechanisms in Plasmodium HSP90 Inhibitors. bioRxiv : the preprint server for biology 0 41279590